SCHEMBL8940068

SCHEMBL8940068

CC1(C)Cc2c(Cl)c([N+](=O)[O-])cc(C(=O)O)c2O1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR35 Q9HC97 1/20 0.35
TSHR P16473 3/20 0.35
ALDH1A1 P00352 4/20 0.34
HTR2A P28223 2/20 0.34
HTR2C P28335 2/20 0.34
HTR2B P41595 2/20 0.34
CYP3A4 P08684 1/20 0.34
HPGD P15428 1/20 0.34
ALOX15 P16050 1/20 0.34
HIF1A Q16665 1/20 0.34
TXNRD1 Q16881 1/20 0.34
TXNRD3 Q86VQ6 1/20 0.34
TXNRD2 Q9NNW7 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
DTYMK P23919 1/20 0.34
POLB P06746 2/20 0.34
PTGES O14684 2/20 0.33
CYP1A2 P05177 2/20 0.33
CYP2D6 P10635 1/20 0.33
CYP2C19 P33261 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29822495 0.89 ALDH1A1 (0.39) GPR35TSHRALDH1A1CYP3A4HPGD
SCHEMBL8939945 0.79 CYP3A4 (0.41) ALDH1A1CYP3A4TDP1POLBPTGES
SCHEMBL13385021 0.72 ALDH1A1 (0.42) GPR35TSHRALDH1A1CYP3A4HPGD
SCHEMBL2696584 0.72 PDGFRB (0.39) ALDH1A1HPGDTDP1POLBCYP1A2
SCHEMBL2697916 0.72 PDGFRB (0.39) TSHRALDH1A1HTR2CHTR2BCYP3A4
SCHEMBL8940038 0.71 TPMT (0.39) ALDH1A1HPGDPOLBPTGESLMNA
SCHEMBL2697504 0.71 PDGFRB (0.39) ALDH1A1TDP1MAPTLMNA
SCHEMBL8939989 0.71 PTGES (0.39) TSHRALDH1A1CYP3A4POLBPTGES
SCHEMBL13385016 0.70 GPR35 (0.38) GPR35TSHRALDH1A1CYP3A4HPGD
SCHEMBL8948739 0.70 TDP1 (0.42) TSHRALDH1A1HTR2AHTR2CHTR2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5563148-A BICYCLIC ESTERS OR AMIDES; USED IN TREATING MIGRAINE, EMESIS, GASTROINTESTINAL DISORDERS, SCHIZOPHRENIA OR ANXIETY IN MAMMALS ELI LILLY AND COMPANY (US) 1996-10-08 US disclosed
EP-0307172-B1 Improvements in or relating to specific 5-HT3 antagonists LILLY CO ELI (US) 1995-10-11 EP disclosed
US-5442078-A Intermediates for specific 5-HT3 antagonists ELI LILLY AND COMPANY (US) 1995-08-15 US disclosed
US-5364863-A Treatment of migraine, emesis, schizophrenia, anxiety, gastrointestinal disorders ELI LILLY AND COMPANY (US) 1994-11-15 US disclosed
US-4997956-A Analgesics ELI LILLY AND COMPANY (US) 1991-03-05 US disclosed
US-4921982-A 5-halo-2,3-dihydro-2,2-dimethylbenzofuran-7-carboxylic acids useful as intermediates for 5-HT3 antagonists ELI LILLY AND COMPANY (US) 1990-05-01 US disclosed
EP-0307172-A2 Improvements in or relating to specific 5-HT3 antagonists ELI LILLY AND COMPANY (US) 1989-03-15 EP disclosed